MESSUEROTTI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 246
EU - Europa 170
AS - Asia 77
OC - Oceania 6
Totale 499
Nazione #
US - Stati Uniti d'America 245
IT - Italia 64
SE - Svezia 41
CN - Cina 33
IE - Irlanda 26
SG - Singapore 16
FR - Francia 9
AT - Austria 7
GB - Regno Unito 7
KR - Corea 7
AU - Australia 6
JP - Giappone 5
BE - Belgio 4
DE - Germania 4
VN - Vietnam 4
MY - Malesia 3
TH - Thailandia 3
FI - Finlandia 2
PH - Filippine 2
PL - Polonia 2
UA - Ucraina 2
UZ - Uzbekistan 2
CA - Canada 1
HK - Hong Kong 1
HU - Ungheria 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 499
Città #
Chandler 46
Dublin 26
Torino 25
Ann Arbor 22
Beijing 14
Singapore 12
Ashburn 10
Medford 9
Nyköping 8
Fairfield 7
Princeton 7
Cambridge 6
Seattle 6
Vienna 6
Villeurbanne 6
Dearborn 5
Houston 5
Woodbridge 5
Brussels 4
Fremont 4
Jacksonville 4
Pisa 4
Rome 4
Turin 4
Boston 3
Guiyang 3
Seoul 3
Wilmington 3
Cagliari 2
Dong Ket 2
Guangzhou 2
Leicester 2
Manchester 2
Milan 2
New York 2
Tokyo 2
Warsaw 2
Washington 2
Atsugi 1
Bangkok 1
Bologna 1
Bucheon 1
Busto Arsizio 1
Capo D'orlando 1
Chengdu 1
Florence 1
Frisco 1
Genova 1
Hangzhou 1
Hebei 1
Helsinki 1
Hilo 1
Hong Kong 1
Innsbruck 1
Kuala Lumpur 1
Los Angeles 1
Melbourne 1
Mountain View 1
Nanjing 1
Nonthaburi 1
Osaka 1
Ravenna 1
Redwood City 1
Repentigny 1
Reutlingen 1
Riverton 1
Rochester 1
San Diego 1
Santa Clara 1
Setapak 1
Shanghai 1
Shenton Park 1
Soc Trang 1
Somerville 1
Tianjin 1
Wuhan 1
Örebro 1
Totale 320
Nome #
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 201
The MEST score provides earlier risk prediction in lgA nephropathy 87
[Renal biopsy practice in Piedmont and Valle d'Aosta] INDAGINE SULLE MODALITÀ DI ESECUZIONE DELLA BIOPSIA RENALE IN PIEMONTE E VALLE D’AOSTA 73
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 59
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 42
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy 37
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort 19
Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy 8
Totale 526
Categoria #
all - tutte 1.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 3 1 8 9 5 6 5 2 4
2020/202180 2 6 4 7 10 3 3 5 13 3 14 10
2021/202293 1 3 2 9 8 3 4 6 9 10 24 14
2022/2023141 12 10 11 5 16 32 8 8 26 3 6 4
2023/202461 7 16 3 3 1 5 1 2 4 4 8 7
2024/202517 4 13 0 0 0 0 0 0 0 0 0 0
Totale 526